Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 500

1.

Metoprolol, but not atenolol, reduces stress induced neuropeptide Y release in pigs.

Åblad B, Bjurö T, Björkman JA, Brax O, Ewaldsson L, Forshult E, Lidfors L, Lundberg JM.

Scand Cardiovasc J. 2010 Oct;44(5):273-8. doi: 10.3109/14017431.2010.498923.

PMID:
21080845
2.

The road ahead for large pharma: long-term science and innovation.

Lundberg JM, Reilly C.

Drug Discov Today. 2009 May;14(9-10):439-41. doi: 10.1016/j.drudis.2009.03.002. Epub 2009 Mar 9. No abstract available.

PMID:
19429501
3.

An audience with... Jan M. Lundberg.

Lundberg JM.

Nat Rev Drug Discov. 2005 Jun;4(6):452. No abstract available.

PMID:
15959949
4.
5.
6.

Postexercise ischemia is associated with increased neuropeptide Y in patients with coronary artery disease.

Gullestad L, Jorgensen B, Bjuro T, Pernow J, Lundberg JM, Dota CD, Hall C, Simonsen S, Ablad B.

Circulation. 2000 Aug 29;102(9):987-93.

PMID:
10961962
7.

Modulation of capsaicin-sensitive nerve activation by low pH solutions in guinea-pig lung.

Auberson S, Lacroix JS, Lundberg JM.

Pharmacol Toxicol. 2000 Jan;86(1):16-23.

PMID:
10720102
8.

Increased spinal cholecystokinin activity after systemic resiniferatoxin: electrophysiological and in situ hybridization studies.

Broberger C, Farkas-Szallasi T, Szallasi A, Lundberg JM, Hökfelt T, Wiesenfeld-Hallin Z, Xu XJ.

Pain. 2000 Jan;84(1):21-8.

PMID:
10601669
10.

Hemodynamic effects of endothelin-1 and big endothelin-1 in chronic hemodialysis patients.

Ottosson-Seeberger A, Ahlborg G, Hemsén A, Lundberg JM, Alvestrand A.

J Am Soc Nephrol. 1999 May;10(5):1037-44.

11.
12.

Effects of systemic resiniferatoxin treatment on substance P mRNA in rat dorsal root ganglia and substance P receptor mRNA in the spinal dorsal horn.

Szallasi A, Farkas-Szallasi T, Tucker JB, Lundberg JM, Hökfelt T, Krause JE.

Brain Res. 1999 Jan 9;815(2):177-84.

PMID:
9878727
13.

Cyclooxygenase inhibition potentiates the renal vascular response to endothelin-1 in humans.

Ahlborg G, Lundberg JM.

J Appl Physiol (1985). 1998 Nov;85(5):1661-6.

14.

Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog.

Malmström RE, Hökfelt T, Björkman JA, Nihlén C, Byström M, Ekstrand AJ, Lundberg JM.

Regul Pept. 1998 Sep 25;75-76:55-70.

PMID:
9802394
15.
16.

The C-terminal fragment of big endothelin-1 does not potentiate the vasoactive effects of endothelin-1.

Ottosson-Seeberger A, Hemsén A, Lundberg JM, Ahlborg G.

Clin Physiol. 1998 Jan;18(1):61-8.

PMID:
9545622
17.
18.

Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.

Malmström RE, Lundberg JM.

Acta Physiol Scand. 1997 Nov;161(3):327-38.

PMID:
9401585
19.

Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans.

Ottosson-Seeberger A, Lundberg JM, Alvestrand A, Ahlborg G.

Acta Physiol Scand. 1997 Oct;161(2):211-20.

PMID:
9366964
21.
22.

Pre- and postjunctional inhibitory effects of fenspiride on guinea-pig bronchi.

Girard V, Naline E, Crambes O, Malbezin M, Malmström RE, Lundberg JM, Advenier C.

Eur Respir J. 1997 May;10(5):1015-20.

23.

Nitric oxide-endothelin-1 interaction in humans.

Ahlborg G, Lundberg JM.

J Appl Physiol (1985). 1997 May;82(5):1593-600.

24.

Effects of the capsaicin analogue resiniferatoxin on spinal nociceptive mechanisms in the rat: behavioral, electrophysiological and in situ hybridization studies.

Xu XJ, Farkas-Szallasi T, Lundberg JM, Hökfelt T, Wiesenfeld-Hallin Z, Szallasi A.

Brain Res. 1997 Mar 28;752(1-2):52-60.

PMID:
9106440
25.

[Blockade of endothelin receptors in cardiovascular diseases. A possible therapeutic alternative in the future].

Pernow J, Lundberg JM.

Lakartidningen. 1997 Mar 19;94(12):1069-73. Review. Swedish. No abstract available.

PMID:
9121239
26.

Long-lasting coronary vasoconstrictor effects and myocardial uptake of endothelin-1 in humans.

Pernow J, Ahlborg G, Lundberg JM, Kaijser L.

Acta Physiol Scand. 1997 Feb;159(2):147-53.

PMID:
9055942
27.

Heavy physical exercise decreases nitric oxide levels in the nasal airways in humans.

Lundberg JO, Rinder J, Weitzberg F, Alving K, Lundberg JM.

Acta Physiol Scand. 1997 Jan;159(1):51-7.

PMID:
9124070
28.

Sodium metabisulfite and citric acid induce bronchoconstriction via a sulfite-sensitive pathway in the isolated guinea pig lung.

Atzori L, Bannenberg G, Corriga AM, Congiu L, Lundberg JM, Moldèus P, Ryrfeldt A.

Respiration. 1997;64(2):145-51.

PMID:
9097350
29.

Nitric oxide and inflammation: the answer is blowing in the wind.

Lundberg JO, Lundberg JM, Alving K, Weitzberg E.

Nat Med. 1997 Jan;3(1):30-1. Review. No abstract available.

PMID:
8986736
30.

Pulmonary chemoreflexes elicited by intravenous injection of lactic acid in anesthetized rats.

Lee LY, Morton RF, Lundberg JM.

J Appl Physiol (1985). 1996 Dec;81(6):2349-57.

31.

Nitric oxide in exhaled air.

Lundberg JO, Weitzberg E, Lundberg JM, Alving K.

Eur Respir J. 1996 Dec;9(12):2671-80. Review.

32.

Inhalation of nasally derived nitric oxide modulates pulmonary function in humans.

Lundberg JO, Settergren G, Gelinder S, Lundberg JM, Alving K, Weitzberg E.

Acta Physiol Scand. 1996 Dec;158(4):343-7.

PMID:
8971255
33.

Effects of the neuropeptide YY1 receptor antagonist SR 120107A on sympathetic vascular control in pigs in vivo .

Malmström RE, Lundberg JM.

Naunyn Schmiedebergs Arch Pharmacol. 1996 Nov;354(5):633-42.

PMID:
8938663
34.
35.

Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis.

Lundberg JO, Ehrén I, Jansson O, Adolfsson J, Lundberg JM, Weitzberg E, Alving K, Wiklund NP.

Urology. 1996 Nov;48(5):700-2.

PMID:
8911512
36.

Comparable potent coronary constrictor effects of endothelin-1 and big endothelin-1 in humans.

Pernow J, Kaijser L, Lundberg JM, Ahlborg G.

Circulation. 1996 Nov 1;94(9):2077-82.

PMID:
8901654
37.

Expression of peptides, nitric oxide synthase and NPY receptor in trigeminal and nodose ganglia after nerve lesions.

Zhang X, Ji RR, Arvidsson J, Lundberg JM, Bartfai T, Bedecs K, Hökfelt T.

Exp Brain Res. 1996 Oct;111(3):393-404.

PMID:
8911933
38.

The effect of endothelin receptor blockade on the development of the Sephadex-induced inflammation in the rat lung.

Andersson SE, Hemsén A, Lundberg JM.

Acta Physiol Scand. 1996 Oct;158(2):189-93.

PMID:
8899066
39.

Recent developments with neuropeptide Y receptor antagonists.

Lundberg JM, Modin A, Malmström RE.

Trends Pharmacol Sci. 1996 Sep;17(9):301-4. Review. No abstract available.

PMID:
8885691
40.

Calcium-independent and steroid-resistant nitric oxide synthase activity in human paranasal sinus mucosa.

Lundberg JO, Weitzberg E, Rinder J, Rudehill A, Jansson O, Wiklund NP, Lundberg JM, Alving K.

Eur Respir J. 1996 Jul;9(7):1344-7.

41.

SR 120107A antagonizes neuropeptide Y Y1 receptor mediated sympathetic vasoconstriction in pigs in vivo.

Malmström RE, Modin A, Lundberg JM.

Eur J Pharmacol. 1996 Jun 3;305(1-3):145-54.

PMID:
8813545
42.

Central and regional hemodynamic effects during infusion of Big endothelin-1 in healthy humans.

Ahlborg G, Ottosson-Seeberger A, Hemsén A, Lundberg JM.

J Appl Physiol (1985). 1996 Jun;80(6):1921-7.

PMID:
8806895
43.

Nasal vasoconstriction and decongestant effects of nitric oxide synthase inhibition in the pig.

Rinder J, Lundberg JM.

Acta Physiol Scand. 1996 Jun;157(2):233-44.

PMID:
8800364
44.

Effects of local and systemic budesonide on allergen-induced airway reactions in the pig.

Fornhem C, Dahlbäck M, Kumlin M, Lundberg JM, Alving K.

Br J Pharmacol. 1996 Jun;118(4):989-97.

45.

Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock.

Weitzberg E, Hemsén A, Rudehill A, Modin A, Wanecek M, Lundberg JM.

Br J Pharmacol. 1996 Jun;118(3):617-26.

46.

[Belching, flatus, breath. Measurements of airborne nitric oxide in the non-invasive diagnosis of inflammation].

Lundberg J, Lundberg JM, Alving K, Weitzberg E.

Lakartidningen. 1996 May 15;93(20):1945-8. Review. Swedish.

PMID:
8667830
47.

Vanilloid receptor loss is independent of the messenger plasticity that follows systemic resiniferatoxin administration.

Farkas-Szallasi T, Bennett GJ, Blumberg PM, Hökfelt T, Lundberg JM, Szallasi A.

Brain Res. 1996 May 6;719(1-2):213-8.

PMID:
8782884
49.

A novel agonist, phorbol 12-phenylacetate 13-acetate 20-homovanillate, abolishes positive cooperativity of binding by the vanilloid receptor.

Szallasi A, Acs G, Cravotto G, Blumberg PM, Lundberg JM, Appendino G.

Eur J Pharmacol. 1996 Mar 28;299(1-3):221-8.

PMID:
8901026
50.

Binding of neuroleptic drugs (trifluoperazine and rimcazole) to vanilloid receptors in porcine dorsal horn.

Szallasi A, Nilsson S, Blumberg PM, Hökfelt T, Lundberg JM.

Eur J Pharmacol. 1996 Mar 18;298(3):321-7.

PMID:
8846833

Supplemental Content

Loading ...
Support Center